American Century Newton Equity Growth Fund

Class Inst (ACLEX)
4 / 5 Stars
5 5 5 5 1
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
A+ (Buy)

#8 in Large Blend

U.S. News evaluated 481 Large Blend Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all American Century Investments funds

See full Large Blend rankings

See more fund rankings


The fund has returned 25.29 percent over the past year, 17.13 percent over the past three years, and 19.12 percent over the past five years.

Trailing Returns Updated 06.30.2014
Year to date 7.2%
1 Year 25.3%
3 Years (Annualized) 17.1%
5 Years (Annualized) 19.1%
10 Years (Annualized) N/A

See more ACLEX performance


The investment seeks long-term capital growth. Under normal market conditions, at least 80% of the fund's net assets will be invested in equity securities. In selecting stocks for the fund, the portfolio managers use quantitative management techniques in a two-step process. First, the managers rank stocks, primarily large capitalization, publicly traded U.S. companies with a market capitalization greater than $2 billion. Second, the portfolio managers use a quantitative model to build a portfolio of stocks from the ranking described above that they believe will provide the optimal balance between risk and expected return.


Fees are Average compared to funds in the same category.
American Century Newton Equity Growth Fund has an expense ratio of 0.48 percent.

See more ACLEX fees


Risk is Average compared to funds in the same category according to Morningstar.

See more ACLEX risk